Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
Clinical trial NCT03164564 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03164564
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2020-11-05
- Enrollment
- 3224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.